Inhibitor of differentiation 4 (Id4) is a potential tumor suppressor in prostate cancer

Jason P W Carey1, Ananthi J Asirvatham, Oliver Galm

  • 1Department of Biology, Center for Cancer Research and Therapeutics Development, Clark Atlanta University, Atlanta, GA 30314, USA. j_carey84@msn.com

BMC Cancer
|June 9, 2009
PubMed
Abstract

Insights

Inhibitor of differentiation 4 (Id4) functions as a tumor suppressor in prostate cancer, with its down-regulation linked to promoter hypermethylation. Restoring Id4 expression inhibits cancer cell proliferation and increases apoptosis.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Epigenetics

Background:

  • Inhibitor of differentiation 4 (Id4) is a dominant-negative regulator of basic helix loop helix (bHLH) transcription factors.
  • Loss of Id4 expression, associated with promoter hypermethylation in many cancers, suggests a tumor suppressor role.
  • This study provides functional evidence for Id4's tumor suppressor activity and its role in cancer-associated epigenetic reprogramming.

Purpose of the Study:

  • To investigate the role of Id4 as a tumor suppressor in prostate cancer.
  • To elucidate the molecular mechanisms underlying Id4 dysregulation in prostate cancer cells.

Main Methods:

  • Data mining to assess Id4 expression in prostate cancer.
  • Methylation-specific polymerase chain reaction (MSP) to analyze Id4 promoter methylation.
  • Functional assays including cell cycle analysis, RT-PCR, real-time PCR, western blot, and immunocytochemistry to evaluate the effects of ectopic Id4 expression.

Main Results:

  • Id4 expression is significantly down-regulated in prostate cancer, particularly in the DU145 cell line, due to promoter hypermethylation.
  • Ectopic Id4 expression in DU145 cells induced apoptosis, decreased cell proliferation via S-phase arrest, and increased expression of p53, p21, p27, and androgen receptor.
  • Ectopic Id4 expression in PC3 cells also led to prolonged G2/M phase arrest.

Conclusions:

  • Id4 functions as a direct tumor suppressor in prostate cancer.
  • Id4 influences multiple cellular processes, including cell proliferation and morphology, potentially by reactivating silenced tumor suppressors.
  • Epigenetic silencing of Id4 contributes to prostate cancer development.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...